GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Hologic, Inc. (HOLX) [hlAlert]

Rating:
Buy HOLX
up 72.79 %

Hologic, Inc. (HOLX) rated Buy by ISI Group

Posted on: Wednesday,  Jan 22, 2014  8:25 AM ET by ISI Group

ISI Group rated Buy Hologic, Inc. (NASDAQ: HOLX) on 01/22/2014. Previously ISI Group rated Strong Buy Hologic, Inc. (NASDAQ: HOLX) on
02/05/2013., when the stock price was $22.75. Since then, Hologic, Inc. has gained 72.79% as of 01/28/2016's recent price of $39.31.
If you would have followed the previous ISI Group's recommendation on HOLX, you would have gained 72.79% of your investment in 1087 days.

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.

ISI Group, founded in 1991, strives to create and deliver the most useful investment research for our clients’ money management performance. Today we are a full service broker-dealer offering macro research, fundamental research, trading, and sales. We have 195 employees around the world with our headquarters in New York and offices located in Boston, Fairhope, London, Los Angeles, San Francisco, Shanghai and Washington DC. Our clients are institutional investors around the world.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/22/2014 8:25 AM Buy
None
21.77
as of 10/17/2014
1 Week down  -0.83 %
1 Month down  -3.24 %
3 Months down  -4.75 %
1 YTD up  6.75 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/21/2013 8:25 AM Buy
None
22.89 26.50
9/24/2013 8:25 AM Buy
None
20.33 25.50
5/7/2013 8:25 AM Buy
None
20.01 24.00
2/5/2013 8:25 AM Buy
None
22.75 27.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy